Enhanced Vector Bioprocessing Technologies for Cell and Gene Therapies

点击翻译按钮获取中文摘要

Evolving therapeutic approaches of cell and gene therapy are harnessing the power of viruses in order tomodify genomes of cells to produce a therapeutic effect. Such therapies are starting to show efficacy in theclinic, but one of the key challenges to their widespread use is the ability to make large quantities of virus at alow cost. This project seeks to address this challenge by creating new methods of producing large quantities ofvirus at a low cost. It brings together Synpromics, a synthetic biology company based in Edinburgh, and the CellTherapy Catapult, one of the UK’s network of Catapult centres focused on developing and growing a cell andgene therapy industry in the UK.